United States Antibodies Market Segmentation Analysis Report 2021-2026 | United States Antibodies Industry Analysis on Size, Share, Growth, Trends, Demand, Competitive Analysis, and Forecast Report 2021-2026

Published: September 2020  |  Report ID:1011  | Pages: 150

United States Antibodies Market – Research Overview:

United States Antibodies Market report published by the Data Research Reports, According to our study the United States Antibodies market is expected to grow at a good CAGR for coming next years. This report analyzed for the antibodies market in United States. The global market was valued at USD 130.9 Bn in 2020, and it is projected to reach USD 225 bn by the end of 2026, with growth at a CAGR of 12% during the forecast period 2021-2026. Including monoclonal & polyclonal antibodies, and growing demand for therapeutic antibodies are the major elements to drive the global antibody market growth over the forecast period. Antibodies are also the leading biopharmaceuticals steering the abnormal cells especially. Several biotechnology and pharma companies have started to concentrate on developing new innovative antibodies to treat chronic diseases, such as arthritis, cancer, and rheumatic heart disease.

What are Antibodies?

Antibodies are immunoglobulins. These antibodies are released by the immune system in humans, that are protect human body from the dangerous viruses (like Coronavirus) enters into the body, these antibodies are in Y-shaped. When an unknown virus enters into the human body then the immune system comes into action and release the antibodies to protect the body. These invaders called antigens, these can be bacteria, viruses, and other chemicals. After an antigen enters into the body it will found by the immune system, the immune system will produce antibodies to destroy the antigens in the body.

Antibodies will be generated and absorbed at foreign proteins, microorganisms, & toxins. These antibodies are used as diagnostics as well as Therapeutic purposes for several symptoms of diseases, including but not limited to rheumatoid arthritis, asthma, macular degeneration, hypercholesterolemia, and Crohn’s disease.

United States Antibodies Market – Growth Factors Analysis:

Including monoclonal & polyclonal antibodies, and growing demand for therapeutic antibodies are the major elements to drive the global antibody market growth over the forecast period. Antibodies are also the leading biopharmaceuticals steering the abnormal cells especially. Several biotechnology and pharma companies have started to concentrate on developing new innovative antibodies to treat chronic diseases, such as arthritis, cancer, and rheumatic heart disease.

The percentage of product approvals in the global antibodies market has increased considerably. In the United States, Europe, and japan the hundreds of monoclonal antibodies have been approved in prominent markets over the past two decades such as; including, Fc-fusion proteins, antibody fragments, therapeutic antibodies, antibody-drug conjugates, etc., So far, Over 74 therapeutic antibodies approved in the United States and Europe, which was characterized by 10.2 percent of the global pharma market in the year 2015. In the previous five years, the therapeutic antibodies sales have increased significantly, because of constant approvals of new antibodies by the regulatory authorities. Although the global antibodies market is facing unmatched initiation of new products, and patent cliffs will be chastening these fatalities.

United States Antibodies Market – Segmentation Analysis:

According to the Data Research Report study, the market has been segmented into By Product Type, By Indication, and By End user.

Based on Product Type, it is further divided into Monoclonal antibodies, Polyclonal antibodies, and Antibody-drug complexes (ADCs). Based on Disease Indication, it is sub classified into cardiovascular diseases, CNS disorders, Cancer, and Autoimmune Disorders. And further based on End User, this segment has been divided into Hospitals, Long-term Care Facilities, and Research institutes.

United States Antibodies Market – Competitive & Major Players:

Data Research Reports insights gives a detailed analysis about growth factors in the united states antibodies market with the benefit of in depth assessment of the competitive atmosphere in the united states antibodies market.

The global antibodies market report provides comprehensive information on major stakeholders in the antibodies market. The prominent key companies listed in the global antibody market report, are Novartis AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi SA, and Eli Lilly and Co.

1. Preface

                1.1 Market Definition and Scope

                1.2 Base Currency, Base Year and Forecast Periods

                1.3 Key Research Objectives

                1.4 Research Highlights

2. General Study Assumptions

3. Research Methodology

                3.1 Introduction

                3.2 Secondary Research

                3.3 Primary Research

                3.4 Analysis Design

                3.5 Study Timeline

4. Market Dynamics

                4.1 Drivers

                4.2 Restraints

                4.3 Opportunities

                4.4 Market Trends

5. Supply Chain Analysis

6. Company Strategy Analysis

                6.1 Merger and Acquisition Analysis

                6.2 Agreements, Collaborations and Joint Ventures

                6.3 Regional Presence

                6.4 New Product Launches

7. Market Outlook

                7.1 Technological Advancement

                7.2 Pricing Analysis

                7.3 Epidemiology

                7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)

8. Market Segmentation

                8.1 Overview

                8.2 United States Antibodies Market, By Product Type, forecast year 2021-2026

                                8.2.1 Monoclonal antibodies

                                8.2.2 Polyclonal antibodies

                                8.2.3 Antibody-drug complexes (ADCs)

                                8.2.4 Market Size Estimations & Forecasts (2021-2026)

                                8.3.5 Y-o-Y Growth Analysis

                                8.3.6 Market Investment Opportunities Analysis

                8.3 United States Antibodies Market, By Disease Indication, forecast year 2021-2026

                                8.3.1 cardiovascular diseases

                                8.3.2 CNS disorders

                                8.3.3 Cancer

                                8.3.4 Autoimmune Disorders

                                8.3.5 Market Size Estimations & Forecasts (2021-2026)

                                8.3.6 Y-o-Y Growth Analysis

                                8.3.7 Market Investment Opportunities Analysis

                8.4 United States Antibodies Market, By End User, forecast year 2021-2026

                                8.4.1 Hospitals

                                8.4.2 Long-term Care Facilities

                                8.4.3 Research institutes

                                8.4.4 Market Size Estimations & Forecasts (2021-2026)

                                8.4.5 Y-o-Y Growth Analysis

                                8.4.6 Market Investment Opportunities Analysis

9. Market Regional and Country Analysis, Forecast 2021-2026

                9.1 Overview

                9.2 Regional Trends

                9.3 Impact Analysis

                9.4 Key Findings

                9.5 United States Antibodies Market,  by Region, 2021-2026

                                9.5.1 By Product Type

                                9.5.2 By Indication

                                9.5.3 By End User

10. Competitive Landscape Analysis

                10.1 Market Player

                                10.1.1 Company Revenue

                                10.1.2 Business unit

                                10.1.3 Product Mapping

                                10.1.4 Geographical Locations

                10.2 Company Share Analysis

11. Strategic Analysis

                11.1 PESTLE analysis

                11.2 Porter’s Five analysis

                                11.2.1 Bargaining Power of Suppliers

                                11.2.2 Bargaining Power of Consumers

                                11.2.3 Threat of New Entrants

                                11.2.4 Threat of Substitute Products and Services

                                11.2.5 Competitive Rivalry within the Industry

12. Company Profiles

                12.1 Novartis AG

                                12.1.1 Overview

                                12.1.2 Product Portfolio

                                12.1.3 Financial Details

                                12.1.4 SWOT Analysis

                                12.1.5 Market Strategies

                12.2 Roche AG

                12.3 Johnson & Johnson

                12.4 Takeda Pharmaceutical Company Limited

                12.5 Amgen Inc

                12.6 Biogen Inc

                12.7 Bristol-Myers Squibb Company

                12.8 AbbVie Inc

                12.9 Sanofi SA

                12.10 Eli Lilly and Co

13. Market Guidance

14. Appendix